Official Journal of the Italian Society of Orthopaedics and Traumatology
VAS | ODI | Paracetamol consumption | |||||||
---|---|---|---|---|---|---|---|---|---|
Control group | CCEF group | p value | Control group | CCEF group | p value | Control group | CCEF group | p value | |
Baseline (mean ± SD) | 8.8 ± 0.7 | 8.2 ± 1.2 | 0.644 | 0.63 ± 0.04 | 0.625 ± 0.06 | 0.644 | – | – | – |
30-day follow-up (mean ± SD) | 5.2 ± 1.3 | 3.5 ± 0.8 | 0.01* | 0.38 ± 0.05 | 0.254 ± 0.07 | 0.01* | 0.86 ± 0.16 | 0.723 ± 0.14 | 0.033* |
60-day follow-up (mean ± SD) | 2.7 ± 0.4 | 1.1 ± 0.3 | 0.02* | 0.21 ± 0.04 | 0.127 ± 0.03 | 0.01* | 0.544 ± 0.25 | 0.224 ± 0.18 | 0.001* |
180-day follow-up (mean ± SD) | 1.02 ± 0.79 | 0.98 ± 0.0.88 | 0.544 | 0.11 ± 0.75 | 0.10 ± 0.97 | 0.424 | 0.17 ± 0.11 | 0.09 ± 0.07 | 0.001* |